Loading data for GPCR — first visit, this takes a few seconds.
Structure Therapeutics In... (GPCR)
NasdaqGM: GPCR
· Real-Time Price · USD
49.78
+0.77 (1.57%)
At close: Aug 21, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
Structure Therapeutics Inc. (GPCR) Stock Price, Analysis & Data
1.57% (1D)
No data available
| Bid | 36.54 |
| Market Cap | 3.5B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -214.84M |
| -1.51 | |
| -3.03 | |
| n/a | |
| -23.21 | |
| P/B (ttm) | 2.58 |
| P/S (ttm) | n/a |
| Earnings Date | Nov 5, 2026 |
| Ask | 64 |
| Volume | 207,022 |
| Avg. Volume (20D) | 714,473 |
| Open | 49.65 |
| Previous Close | 49.01 |
| Day's Range | 49.59 - 51.02 |
| 52-Week Range | 18.26 - 94.90 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About GPCR
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, which is in two phase 2 clinical trials for the treatment of obesity, overweight, and related conditions. Th...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 3, 2023
Employees 281
Stock Exchange NasdaqGM
Ticker Symbol GPCR
Website https://structuretx.com
Financial Performance
In 2025, Structure Therapeutics's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -141.2M, an increase of 15.24%.
Financial StatementsEarnings Surprise
Structure Therapeutics has released their quarterly earnings on Aug 6, 2026:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -0.49 misses estimates by -0.11, with -36.11% YoY decline.
Structure Therapeutics Inc. is scheduled to release its earnings on Nov 5, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade